i-ED COIL 390-0204Recalls & reported problems
Kaneka Corporation · The i-ED COIL is used for vascular embolization with a platinum coil at the target lesion in the patient’s blood vessel. · Class 2 · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 04540778176515), received between Sep 15, 2023 and Sep 15, 2023 — classified as 2 injuries.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
Patient problems
- Aneurysm1
- Ruptured Aneurysm1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjurySep 15, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
1ST COIL IN THE ICA WAS IMPLANTED AND DURING THE DEPLOYMENT OF THE LAST 1CM OF THE 2X4 SS, THE ANEURYSM RUPTURED. NOTED A NEW CATHETER(HEADWAY (17) WAS USED BEFORE THE COIL WAS DEPLOYED AND NO MENTION FROM THE MD THAT THE COIL WAS AT FAULT. THE SAME 2X4 SS WAS IMPLANTED THREE TIMES PRIOR WITH NO INCIDENT WITH A 156 HEADWAY DUO. EACH OF THE THREE 1ST ATTEMPTS THE LAST PORTION OF THE COIL KICKED OUT THE 156 HEADWAY DUO OUT OF THE ANEURYSM. THE RUPTURE OCCURRED WITH THE 4TH ATTEMPT WITH THE SAME 2X4 SS AND THE 1ST TIME USING THE HEADWAY 17 CATHETER. ONE ADDITIONAL COIL WAS PLACED, AND THE ANEURYSM WAS OCCLUDED. PATIENT WAS STABLE AFTER ANOTHER COIL WAS GIVEN AND COILING WAS COMPLETE. MANUFACTURER REPORT # 3009761573-2023-00003.
Patient problems: Aneurysm
MAUDE report 17754331 ↗InjurySep 15, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
1ST COIL IN THE ICA WAS IMPLANTED AND DURING THE DEPLOYMENT OF THE LAST 1CM OF THE 2X4 SS, THE ANEURYSM RUPTURED. NOTED A NEW CATHETER(HEADWAY 17) WAS USED BEFORE THE COIL WAS DEPLOYED AND NO MENTION FROM THE MD THAT THE COIL WAS AT FAULT. THE SAME 2X4 SS WAS IMPLANTED THREE TIMES PRIOR WITH NO INCIDENT WITH A 156 HEADWAY DUO. EACH OF THE THREE 1ST ATTEMPTS THE LAST PORTION OF THE COIL KICKED OUT THE 156 HEADWAY DUO OUT OF THE ANEURYSM. THE RUPTURE OCCURRED WITH THE 4TH ATTEMPT WITH THE SAME 2X4 SS AND THE 1ST TIME USING THE HEADWAY 17 CATHETER. ONE ADDITIONAL COIL WAS PLACED, AND THE ANEURYSM WAS OCCLUDED. PATIENT WAS STABLE AFTER ANOTHER COIL WAS GIVEN AND COILING WAS COMPLETE.
Patient problems: Ruptured Aneurysm
MAUDE report 17752991 ↗
Other Device, Neurovascular Embolization devices
- POD RBYPODJ60-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION355 reports
- Penumbra System SCH1Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION295 reports
- RUBY Coil RBY4C0860-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION276 reports
- Smart Coil 400SMTHXSFT0208Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION165 reports
- Penumbra System RH1-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION154 reports
- Optima Coil System OPTI0208CSS10Balt USA LLC · Device, Neurovascular Embolization3 recalls3 reports
- POD RBYPOD6-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION148 reports
- POD RBYPODJ30-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION132 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page